Valion Bio VBIO
NASDAQ VBIO
$0.12 0.00 (-0.90%)
As of: Aug 21, 2026 · 11:20 AM EDT

Valion Bio (VBIO) Share-based Compensation (2021 - 2026)

Valion Bio (VBIO) posted quarterly Share-based Compensation of -$322000.0 for Q4 2025, down 333.33% quarter-over-quarter from $138000.0 in Q3 2025.

Valion Bio (VBIO) Share-based Compensation (2021 - 2026) Analysis & Trends

Valion Bio's Share-based Compensation history runs 5 years deep, the most recent figure standing at -$322000.0 for Q4 2025.

  • In Q4 2025, Share-based Compensation changed N/A year-over-year to -$322000.0; the TTM figure through Dec 2025 stood at -$84000.0 (down 150.6% YoY), while the FY2025 annual figure was $974000.0, up 342.73% from the prior year.
  • Share-based Compensation for Q4 2025 stood at -$322000.0, down from $138000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $225000.0 in Q4 2022, with the low at -$322000.0 in Q4 2025.
  • The 5-year median for Share-based Compensation is $58000.0 (2023), against an average of $53894.7.
  • The sharpest annual moves came in 2022 and 2023: Share-based Compensation soared 1306.25% in 2022, then slumped 74.22% in 2023.
  • Valion Bio's Share-based Compensation stood at $16000.0 in 2021, then jumped by 1306.25% to $225000.0 in 2022, then plunged by 74.22% to $58000.0 in 2023, then changed by 0.0% to $58000.0 in 2024, then plunged by 655.17% to -$322000.0 in 2025.
  • Business Quant data shows VBIO's Share-based Compensation at -$322000.0 in Q4 2025, $138000.0 in Q3 2025, and $104000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Vertex Pharmaceuticals 139.99 Bn 132.14 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 86.80 Bn 78.80 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 65.38 Bn 60.19 Bn 1.37 Bn -
4 Moderna 60.70 Bn 55.56 Bn 52.00 Mn 120.00 Mn
5 BeOne Medicines 42.22 Bn 37.12 Bn 1.53 Bn 137.41 Mn
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 86.63 Mn
7 BioNTech SE 28.45 Bn 10.06 Bn 668.28 Mn 28.05 Mn
8 Insmed 27.47 Bn 26.31 Bn 358.27 Mn 41.25 Mn
9 Royalty Pharma 27.21 Bn 26.37 Bn - -
10 Valion Bio 411,683.63 -1.79 Mn -45,000.00 133,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 133,000.00
Jun 30, 2026 133,000.00
Dec 31, 2025 -322,000.00
Dec 31, 2025 -322,000.00
Sep 30, 2025 138,000.00
Sep 30, 2025 138,000.00
Jun 30, 2025 104,000.00
Jun 30, 2025 104,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Sep 30, 2024 58,000.00
Sep 30, 2024 58,000.00
Jun 30, 2024 54,000.00
Jun 30, 2024 54,000.00
Mar 31, 2024 54,000.00
Mar 31, 2024 54,000.00
Dec 31, 2023 58,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 48,000.00
Sep 30, 2023 48,000.00